SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $266,326 | +8.0% | 9,660 | +17.7% | 0.02% | +15.4% |
| Q2 2023 | $246,672 | -20.7% | 8,206 | -4.4% | 0.01% | -31.6% |
| Q1 2023 | $311,143 | +27.0% | 8,588 | +16.5% | 0.02% | +26.7% |
| Q4 2018 | $245,000 | -50.8% | 7,373 | -25.5% | 0.02% | -21.1% |
| Q3 2018 | $498,000 | -26.4% | 9,896 | -12.5% | 0.02% | -29.6% |
| Q2 2018 | $677,000 | +45.6% | 11,310 | +11.5% | 0.03% | +42.1% |
| Q1 2018 | $465,000 | +57.1% | 10,148 | +36.6% | 0.02% | +72.7% |
| Q4 2017 | $296,000 | +17.0% | 7,429 | +17.5% | 0.01% | 0.0% |
| Q3 2017 | $253,000 | -36.4% | 6,322 | -31.6% | 0.01% | -38.9% |
| Q2 2017 | $398,000 | +45.8% | 9,243 | +6.0% | 0.02% | +50.0% |
| Q1 2017 | $273,000 | +11.4% | 8,717 | -10.2% | 0.01% | +9.1% |
| Q4 2016 | $245,000 | – | 9,703 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |